Table 2. Initial Treatment Strategies and Outcomes of Patients with Endophthalmitis caused by Klebsiella species.
Patient | Presenting VA | Initial Treatment | Clinical Improvement | Follow-up (months) | Last VA |
---|---|---|---|---|---|
1 | 2/200 | Vitreous tap/injection | No | 1 | enucleated |
2 | 1/200 | PPV with intravitreal injection | No | 4 | enucleated |
3 | Light perception | Vitreous tap/injection | No | 20 | eviscerated |
4 | Light perception | PPV with intravitreal injection | Yes | 2 | 20/60 |
5 | 20/60 | Anterior chamber tap/injection* | Yes | 4 | 20/25 |
6 | Hand movements | Vitreous tap/injection | Yes | 83 | 20/70 |
7 | Hand movements | Vitreous tap/injection | No+ | 76 | 20/70 |
VA: Snellen visual acuity; Last VA: visual acuity at last follow-up examination; PPV: pars plana vitrectomy
Patient 5 underwent repair of corneal laceration simultaneously
Patient 7 subsequently underwent pars plana vitrectomy